Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6097)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2014 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Wójcik K, Jabłonowska E, Omulecka A, Piekarska A. Insulin resistance, adipokine profile and hepatic expression of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i30/10449.htm |
| Number | Citing Articles |
| 1 |
Ding Liu, Shengyu Li, Zhihong Li. Adiponectin: A biomarker for chronic hepatitis C?. Cytokine 2017; 89: 27 doi: 10.1016/j.cyto.2015.10.016
|
| 2 |
Raika Jamali, Mohsen Razavizade, Abbas Arj, Mohammad Hossein Aarabi. Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(21): 5096-5103 doi: 10.3748/wjg.v22.i21.5096
|
| 3 |
D. Crisan, C. Radu, A. Suciu, N. Leach, H. Stefanescu, L. Avram, N. Crisan, M. Grigorescu. Hepatitis C in nonobese nondiabetic patients: Insulin resistance and the metabolic syndrome make a difference. Journal of Viral Hepatitis 2017; 24(1): 86 doi: 10.1111/jvh.12610
|
| 4 |
Chulbul M. Ahmed, Tristan R. Grams, David C. Bloom, Howard M. Johnson, Alfred S. Lewin. Individual and Synergistic Anti-Coronavirus Activities of SOCS1/3 Antagonist and Interferon α1 Peptides. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.902956
|
| 5 |
Zhenhua Liu, Lanting Xu, Meimei Xing, Xiaojie Xu, Jinfeng Wei, Jinmei Wang, Wenyi Kang. Trelagliptin succinate: DPP-4 inhibitor to improve insulin resistance in adipocytes. Biomedicine & Pharmacotherapy 2020; 125: 109952 doi: 10.1016/j.biopha.2020.109952
|
| 6 |
Marian-Sorin Popescu, Andrei Ioan Drocas, Andrei Osman, Dan-Mihai Firu, Vlad Pădureanu, Cristina Maria Mărginean, Daniel-Cristian Pîrvu, Radu Mitruț, Dragoș Nicolae Mărgăritescu, Antonia Radu, Daniela Calina, Anca Oana Docea, Paul Mitruț. The Extent of Insulin Resistance in Patients That Cleared Viral Hepatitis C Infection and the Role of Pre-Existent Type 2 Diabetes Mellitus: A Meta-Analysis. Reports 2022; 5(4): 42 doi: 10.3390/reports5040042
|
| 7 |
Ester Vanni, Elisabetta Bugianesi, Giorgio Saracco. Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?. Digestive and Liver Disease 2016; 48(2): 105 doi: 10.1016/j.dld.2015.10.016
|
| 8 |
Georg Peschel, Kilian Weigand, Jonathan Grimm, Martina Müller, Christa Buechler. Serum omentin-1 is correlated with the severity of liver disease in patients with chronic hepatitis C. World Journal of Hepatology 2023; 15(12): 1315-1324 doi: 10.4254/wjh.v15.i12.1315
Abstract(323) |
Core Tip(292) |
Full Article(HTML)(862)
|
Full Article with Cover (PDF)-6085K(59)
|
Full Article (Word)-362K(21)
|
Audio-1515K(7)
|
Peer-Review Report-219K(56)
|
Answering Reviewers-49K(61)
|
Full Article (PDF)-1065K(65)
|
Full Article (XML)-105K(37)
|
Times Cited (1)
|
Total Visits (3374)
|
Open
|
| 9 |
Shinji Iwane, Toshihiko Mizuta, Yasunori Kawaguchi, Hirokazu Takahashi, Noriko Oza, Satoshi Oeda, Shunya Nakashita, Takuya Kuwashiro, Taiga Otsuka, Seiji Kawazoe, Yuichiro Eguchi, Keizo Anzai, Iwata Ozaki, Kazuma Fujimoto. Impact of Body Weight Reduction via Diet and Exercise on the Anti-Viral Effects of Pegylated Interferon Plus Ribavirin in Chronic Hepatitis C Patients with Insulin Resistance: A Randomized Controlled Pilot Trial. Internal Medicine 2015; 54(24): 3113 doi: 10.2169/internalmedicine.54.5574
|